32.63 USD
-0.72 (-2.16%)
At close: Jan 30, 2026
32.63 USD
0 (0%)
After Hours: 1/30/2026, 8:00:01 PM
GMAB gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. GMAB gets an excellent profitability rating and is at the same time showing great financial health properties. GMAB is growing strongly while it is still valued neutral. This is a good combination! These ratings could make GMAB a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year GMAB was profitable.
- GMAB had a positive operating cash flow in the past year.
- In the past 5 years GMAB has always been profitable.
- GMAB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of GMAB (21.10%) is better than 97.33% of its industry peers.
- The Return On Equity of GMAB (25.76%) is better than 97.14% of its industry peers.
- GMAB has a better Return On Invested Capital (17.11%) than 96.76% of its industry peers.
- GMAB had an Average Return On Invested Capital over the past 3 years of 15.20%. This is below the industry average of 18.07%.
- The last Return On Invested Capital (17.11%) for GMAB is above the 3 year average (15.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 21.1% | ||
| ROE | 25.76% | ||
| ROIC | 17.11% |
ROA(3y)15.92%
ROA(5y)16.24%
ROE(3y)18.48%
ROE(5y)18.5%
ROIC(3y)15.2%
ROIC(5y)16.1%
1.3 Margins
- With an excellent Profit Margin value of 41.35%, GMAB belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
- GMAB's Profit Margin has declined in the last couple of years.
- GMAB has a Operating Margin of 36.85%. This is amongst the best in the industry. GMAB outperforms 97.90% of its industry peers.
- In the last couple of years the Operating Margin of GMAB has declined.
- GMAB has a Gross Margin of 94.27%. This is amongst the best in the industry. GMAB outperforms 94.86% of its industry peers.
- GMAB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 36.85% | ||
| PM (TTM) | 41.35% | ||
| GM | 94.27% |
OM growth 3Y-2.13%
OM growth 5Y-7.73%
PM growth 3Y1.23%
PM growth 5Y-2.03%
GM growth 3Y-1.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GMAB is creating value.
- Compared to 1 year ago, GMAB has less shares outstanding
- The number of shares outstanding for GMAB has been reduced compared to 5 years ago.
- The debt/assets ratio for GMAB is higher compared to a year ago.
2.2 Solvency
- GMAB has an Altman-Z score of 12.28. This indicates that GMAB is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 12.28, GMAB belongs to the best of the industry, outperforming 84.57% of the companies in the same industry.
- GMAB has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
- The Debt to FCF ratio of GMAB (0.12) is better than 95.81% of its industry peers.
- A Debt/Equity ratio of 0.02 indicates that GMAB is not too dependend on debt financing.
- GMAB has a Debt to Equity ratio (0.02) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.12 | ||
| Altman-Z | 12.28 |
ROIC/WACC2.34
WACC7.32%
2.3 Liquidity
- GMAB has a Current Ratio of 6.03. This indicates that GMAB is financially healthy and has no problem in meeting its short term obligations.
- GMAB's Current ratio of 6.03 is fine compared to the rest of the industry. GMAB outperforms 62.86% of its industry peers.
- A Quick Ratio of 6.01 indicates that GMAB has no problem at all paying its short term obligations.
- GMAB has a Quick ratio of 6.01. This is in the better half of the industry: GMAB outperforms 63.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.03 | ||
| Quick Ratio | 6.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 125.90% over the past year.
- GMAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.38% yearly.
- The Revenue has grown by 24.66% in the past year. This is a very strong growth!
- GMAB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.16% yearly.
EPS 1Y (TTM)125.9%
EPS 3Y34.24%
EPS 5Y28.38%
EPS Q2Q%121.44%
Revenue 1Y (TTM)24.66%
Revenue growth 3Y32.63%
Revenue growth 5Y31.16%
Sales Q2Q%-81.55%
3.2 Future
- Based on estimates for the next years, GMAB will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.30% on average per year.
- Based on estimates for the next years, GMAB will show a quite strong growth in Revenue. The Revenue will grow by 13.38% on average per year.
EPS Next Y6.42%
EPS Next 2Y-1.8%
EPS Next 3Y6.27%
EPS Next 5Y9.3%
Revenue Next Year22.77%
Revenue Next 2Y19.6%
Revenue Next 3Y17.39%
Revenue Next 5Y13.38%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.83 indicates a correct valuation of GMAB.
- GMAB's Price/Earnings ratio is rather cheap when compared to the industry. GMAB is cheaper than 96.76% of the companies in the same industry.
- GMAB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.30.
- With a Price/Forward Earnings ratio of 19.17, GMAB is valued on the expensive side.
- Based on the Price/Forward Earnings ratio, GMAB is valued cheaply inside the industry as 93.90% of the companies are valued more expensively.
- GMAB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.83 | ||
| Fwd PE | 19.17 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GMAB is valued cheaper than 96.76% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GMAB indicates a rather cheap valuation: GMAB is cheaper than 96.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.7 | ||
| EV/EBITDA | 11.27 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- GMAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)0.49
EPS Next 2Y-1.8%
EPS Next 3Y6.27%
5. Dividend
5.1 Amount
- No dividends for GMAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GENMAB A/S -SP ADR / GMAB FAQ
What is the ChartMill fundamental rating of GENMAB A/S -SP ADR (GMAB) stock?
ChartMill assigns a fundamental rating of 7 / 10 to GMAB.
What is the valuation status for GMAB stock?
ChartMill assigns a valuation rating of 6 / 10 to GENMAB A/S -SP ADR (GMAB). This can be considered as Fairly Valued.
Can you provide the profitability details for GENMAB A/S -SP ADR?
GENMAB A/S -SP ADR (GMAB) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for GMAB stock?
The Price/Earnings (PE) ratio for GENMAB A/S -SP ADR (GMAB) is 13.83 and the Price/Book (PB) ratio is 3.5.
Can you provide the financial health for GMAB stock?
The financial health rating of GENMAB A/S -SP ADR (GMAB) is 8 / 10.